The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke

Cerebrovascular Diseases

Volumn 37, Issue 2, 2014, Pages 128-133

  Fischer, Marlene ^a   Katan, Mira ^b   Morgenthaler, Nils G ^d   Seiler, Marleen ^e   Müller, Beat ^c   Lackner, Peter ^a   Errath, Mario ^a   Helbok, Raimund ^a   Pfausler, Bettina ^a   Beer, Ronny ^a   Schmutzhard, Erich ^a   Broessner, Gregor ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

Atrial natriuretic peptide; Intracerebral hemorrhage; Outcome; Subarachnoid hemorrhage

Indexed keywords

MIDREGIONAL PROATRIAL NATRIURETIC PEPTIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; ANTIPYRETIC AGENT; ATRIAL NATRIURETIC FACTOR;

ADULT; APACHE; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FEVER; GLASGOW OUTCOME SCALE; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; INDUCED HYPOTHERMIA; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; STROKE;

EID: 84893201060     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000357215     Document Type: Article

References (30)

1. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF: Spontaneous in-tracerebral hemorrhage. N Engl J Med 2001; 344:1450-1460.
2. Suarez JI, Tarr RW, Selman WR: Aneurysmal subarachnoid hemorrhage. N Engl J Med 2006; 354:387-396.
3. Broessner G, Helbok R, Lackner P, Mitter-berger M, Beer R, Engelhardt K, Brenneis C, Pfausler B, Schmutzhard E: Survival and long-term functional outcome in 1, 155 consecutive neurocritical care patients. Crit Care Med 2007; 35:2025-2030.
4. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004; 350:655-663.
5. Suttner SW, Boldt J: Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care 2004; 10:336-341.
6. Nogami M, Shiga J, Takatsu A, Endo N, Ishi-yama I: Immunohistochemistry of atrial na-triuretic peptide in brain infarction. Histo-chem J 2001; 33:87-90.
7. Giuffrida R, Bellomo M, Polizzi G, Malatino LS: Ischemia-induced changes in the immuno-reactivity for endothelin and other vasoactive peptides in the brain of the Mongolian gerbil. J Cardiovasc Pharmacol 1992; 20(Suppl 12): S41-S44.
8. Davidson NC, Coutie WJ, Struthers AD: N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro. Circulation 1995; 91:1276-1277.
9. Morgenthaler NG, Struck J, Thomas B, Berg-mann A: Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 2004; 50: 234-236.
10. Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, Bingisser R, Kappos L, Steck A, Engelter ST, Müller B, Christ-Crain M: Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. J Am Coll Cardiol 2010; 56: 1045-1053.
11. Makikallio AM, Makikallio TH, Korpelainen JT, Vuolteenaho O, Tapanainen JM, Ylitalo K, Sotaniemi KA, Huikuri HV, Myllyla VV: Na-triuretic peptides and mortality after stroke. Stroke 2005; 36:1016-1020.
12. Broessner G, Beer R, Lackner P, Helbok R, Fischer M, Pfausler B, Rhorer J, Küppers-Tiedt L, Schneider D, Schmutzhard E: Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke 2009; 40:e657-e665.
13. Daniels LB, Clopton P, Potocki M, Mueller C, McCord J, Richards M, Hartmann O, Anand IS, Wu AH, Nowak R, Peacock WF, Poni-kowski P, Mockel M, Hogan C, Filippatos GS, Di Somma S, Ng L, Neath SX, Christenson R, Morgenthaler NG, Anker SD, Maisel AS: Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study. Eur J Heart Fail 2012; 14:22-31.
14. Schnabel RB, Schulz A, Messow CM, Lubos E, Wild PS, Zeller T, Sinning CR, Rupprecht HJ, Bickel C, Peetz D, Cambien F, Kempf T, Wol-lert KC, Benjamin EJ, Lackner KJ, Munzel TF, Tiret L, Vasan RS, Blankenberg S: Multiple marker approach to risk stratification in patients with stable coronary artery disease. Eur Heart J 2010; 31:3024-3031.
15. Kruger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T: Pro-atrial natriuret-ic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ. Intensive Care Med 2007; 33:2069-2078.
16. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papas-sotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD: Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol 2007; 50:1973-1980.
17. Wijdicks EF, Schievink WI, Burnett JC Jr: Na-triuretic peptide system and endothelin in an-eurysmal subarachnoid hemorrhage. J Neu-rosurg 1997; 87:275-280.
18. Nakamura T, Okuchi K, Matsuyama T, Fuku-shima H, Seki T, Konobu T, Nishio K: Clinical significance of elevated natriuretic peptide levels and cardiopulmonary parameters after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2009; 49: 185-191, discussion 191-192.
19. James ML, Blessing R, Phillips-Bute BG, Bennett E, Laskowitz DT: S100B and brain natri-uretic peptide predict functional neurological outcome after intracerebral haemorrhage. Biomarkers 2009;14: 388-394.
20. Levin ER, Gardner DG, Samson WK: Natri-uretic peptides. N Engl J Med 1998; 339:321-328.
21. Hasegawa K, Fix ML, Wendell L, Schwab K, Ay H, Smith EE, Greenberg SM, Rosand J, Goldstein JN, Brown DF: Ischemic-appearing electrocardiographic changes predict myocar-dial injury in patients with intracerebral hemorrhage. Am J Emerg Med 2012; 30: 545-552.
22. Lee VH, Oh JK, Mulvagh SL, Wijdicks EF: Mechanisms in neurogenic stress cardiomy-opathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2006; 5:243-249.
23. Temes RE, Tessitore E, Schmidt JM, Naidech AM, Fernandez A, Ostapkovich ND, Frontera JA, Wartenberg KE, Di Tullio MR, Badjatia N, Connolly ES, Mayer SA, Parra A: Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhage. Neurocrit Care 2010; 13:359-365.
24. van Bree MD, Roos YB, van der Bilt IA, Wilde AA, Sprengers ME, de Gans K, Vergouwen MD: Prevalence and characterization of ECG abnormalities after intracerebral hemorrhage. Neurocrit Care 2010; 12:50-55.
25. Jespersen CM, Fischer Hansen J: Myocardial stress in patients with acute cerebrovascular events. Cardiology 2008; 110:123-128.
26. Tota B, Cerra MC, Gattuso A: Catechol-amines, cardiac natriuretic peptides and chromogranin A: evolution and physiopa-thology of a 'whip-brake' system of the endocrine heart. J Exp Biol 2010; 213:3081-3103.
27. Moussouttas M, Huynh TT, Khoury J, Lai EW, Dombrowski K, Pello S, Pacak K: Cere-brospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage. Cerebrovasc Dis 2012; 33:173-181.
28. Oddo M: Prognostication after cardiac arrest: time to change our approach. Resuscitation 2012; 83:149-150.
29. Rossetti AO, Oddo M, Logroscino G, Kaplan PW: Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neu-rol 2010; 67:301-307.
30. Storm C, Nee J, Jorres A, Leithner C, Hasper D, Ploner CJ: Serial measurement of neuron specific enolase improves prognostication in cardiac arrest patients treated with hypothermia: a prospective study. Scand J Trauma Re-susc Emerg Med 2012; 20:6.